Status:

COMPLETED

The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

Lustgarten Foundation

Conditions:

Pancreatic Cysts

Pancreatic Cancer

Eligibility:

All Genders

18+ years

Brief Summary

The aim is to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant pancreatic cysts using a combination...

Detailed Description

This combined cross-sectional and prospective single center clinical and translational study involves a collaborative multidisciplinary team composed of gastroenterologists, surgeons, radiologists, an...

Eligibility Criteria

Inclusion

  • Adult patients age 18 years and older
  • Referred for assessment of one or more pancreatic cyst.

Exclusion

  • Medically ill patients with ASA class 4 or greater.
  • History of chronic kidney disease with a serum creatinine \> 2.0 mg/dl or estimated glomerulofiltration rate (eGFR) \< 30 ml/min, dialysis patients, acute renal failure, cirrhosis of the liver, chronic hepatitis, prior nephrectomy or kidney or liver transplantation.
  • History of moderate (generalized hives) or severe (facial swelling, airway reaction) reaction to intravenous radiographic contrast material.
  • History of obstruction in the upper GI tract such as esophageal or pyloric stricture, which would not allow passage of an endoscope.
  • Bleeding diathesis (clotting problems) or a history of thrombocytopenia (low platelet count \<50,000).
  • Inability to provide informed consent.
  • Pregnancy or lactation.

Key Trial Info

Start Date :

October 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2019

Estimated Enrollment :

477 Patients enrolled

Trial Details

Trial ID

NCT01202136

Start Date

October 1 2012

End Date

September 1 2019

Last Update

October 22 2019

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Johns Hopkins Hospital

Baltimore, Maryland, United States, 21231

2

Johns Hopkins Medicine

Baltimore, Maryland, United States, 21287